Kliniske studier for Demens i New Jersey
8 studier for Demens søker deltakere på steder i New Jersey.
Byer i New Jersey
Offisiell studietekst (engelsk)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06887192Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
- Kessler Foundation, East Hanover
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05048966A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- The Cognitive and Research Center of New Jersey, Springfield
- Advanced Clinical Institute, West Long Branch
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06976203A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
RekruttererFase 1
Alder 50 til 85 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Advanced Memory Research Institute of New Jersey, Toms River
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06976216A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- The Cognitive and Research Center of New Jersey, Springfield
RekruttererFase 3
Alder 55 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT07602582Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- Nuclear Imaging Institute, Englewood
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
Alder 18 til 120 · Alle kjønn · Oppdatert 13. apr. 2026 · NCT07012993Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 2. feb. 2026 · NCT07105709Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.